Assignee
ASCENEURON SA
CH·19 granted patents·3 pending applications·125 citations·filing 2014–2024
Top patents by PatentIndex Score
22 records- 0196US11591327B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2020·Granted Feb 28, 2023·6 cites·4 claims
- 0296US11261183B2Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Mar 1, 2022·11 cites·3 claims
- 0396US11046712B2Glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Jun 29, 2021·11 cites·20 claims
- 0495US10995090B2Substituted dihydrobenzofuran glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted May 4, 2021·11 cites·16 claims
- 0595US10344021B2Process for the separation of enantiomers of piperazine derivativesASCENEURON SA·Filed 2017·Granted Jul 9, 2019·15 cites·20 claims
- 0694US11213525B2Linear glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Jan 4, 2022·9 cites·10 claims
- 0794US10696668B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2017·Granted Jun 30, 2020·12 cites·2 claims
- 0894US10336775B2Glycosidase inhibitorsASCENEURON SA·Filed 2015·Granted Jul 2, 2019·15 cites·3 claims
- 0992US10556902B2Glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Feb 11, 2020·12 cites·12 claims
- 1091US11612599B2Glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Mar 28, 2023·6 cites·11 claims
- 1190US12157734B2Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2021·Granted Dec 3, 2024·1 cites·12 claims
- 1289US12187741B2Glycosidase inhibitorsASCENEURON SA·Filed 2021·Granted Jan 7, 2025·1 cites·1 claims
- 1388US11795165B2Tetrahydro-benzoazepine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Oct 24, 2023·5 cites·12 claims
- 1488US11731972B2Spiro compounds as glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Aug 22, 2023·5 cites·15 claims
- 1586US12016852B2Pyrrolidine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Jun 25, 2024·4 cites·16 claims
- 1682US2025115604A1Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2024·Application pending·0 cites
- 1778US12195455B2Succinate and fumarate acid addition salts of piperazine derivativesASCENEURON SA·Filed 2019·Granted Jan 14, 2025·1 cites·2 claims
- 1876US12398130B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2022·Granted Aug 26, 2025·0 cites·6 claims
- 1949US2022143042A1Fused glycosidase inhibitorsASCENEURON SA·Filed 2020·Application pending·0 cites
- 2046US2024285615A1Medicaments comprising glycosidase inhibitorsASCENEURON SA·Filed 2021·Application pending·0 cites
- 2141US11458140B2Annulated glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Oct 4, 2022·0 cites·22 claims
- 2240US9505769B2Tetraaza-cyclopenta[a]indenyl derivativesASCENEURON SA·Filed 2014·Granted Nov 29, 2016·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when ASCENEURON SA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →